Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
83.59
+0.27 (0.32%)
Nov 20, 2024, 4:00 PM EST - Market closed
Globus Medical Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Globus Medical stock have an average target of 86.15, with a low estimate of 71 and a high estimate of 100. The average target predicts an increase of 3.06% from the current stock price of 83.59.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Globus Medical stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 3 | 3 | 4 | 4 | 4 | 4 |
| Hold | 4 | 4 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $74 → $83 | Hold | Maintains | $74 → $83 | -0.71% | Nov 11, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 7, 2024 |
| Stifel | Stifel | Strong Buy Maintains $80 → $92 | Strong Buy | Maintains | $80 → $92 | +10.06% | Nov 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $79 → $85 | Strong Buy | Maintains | $79 → $85 | +1.69% | Nov 6, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +19.63% | Nov 6, 2024 |
Financial Forecast
Revenue This Year
2.55B
from 1.57B
Increased by 62.26%
Revenue Next Year
2.72B
from 2.55B
Increased by 6.76%
EPS This Year
2.98
from 1.07
Increased by 178.06%
EPS Next Year
3.49
from 2.98
Increased by 17.24%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.6B | 2.8B | 3.0B | ||
| Avg | 2.5B | 2.7B | 2.9B | ||
| Low | 2.4B | 2.6B | 2.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 67.4% | 10.8% | 11.5% | ||
| Avg | 62.3% | 6.8% | 6.8% | ||
| Low | 54.9% | 1.7% | -0.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.34 | 3.78 | 4.28 | ||
| Avg | 2.98 | 3.49 | 3.98 | ||
| Low | 2.72 | 3.23 | 3.46 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 212.1% | 27.1% | 22.6% | ||
| Avg | 178.1% | 17.2% | 14.2% | ||
| Low | 154.6% | 8.6% | -0.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.